Dr Reddy launches world's 1st immuno-onco drug for nasopharyngeal cancer in India

Thursday, 28 November 2024
Dr Reddy’s Laboratories launches Toripalimab, the first immuno-oncology drug for nasopharyngeal carcinoma, in India. Toripalimab, a PD-1 inhibitor, provides a new treatment option for this rare head and neck cancer, which previously relied on chemotherapy. India joins China and the US in offering this groundbreaking therapy that reduces risk of progression or death by 48%.

👓 View full article

0 shares	Share Tweet Save Post Send

Video Credit: Oneindia - Published on November 28, 2024

"Ceasefire with Hezbollah...": Israel's Ambassador to India Meets Telangana CM Reddy in Hyderabad 05:37

In an exclusive meeting with Telangana Chief Minister Revanth Reddy, Israel's Ambassador to India, Reuven Azar, shared critical insights on the ongoing ceasefire between Israel and Hezbollah. This video uncovers the key details discussed during the meeting, shedding light on the delicate peace...

Dr Reddy launches world's 1st immuno-onco drug for nasopharyngeal cancer in India

"Ceasefire with Hezbollah...": Israel's Ambassador to India Meets Telangana CM Reddy in Hyderabad 05:37

💡 newsR Knowledge: Other News Mentions

You Might Like